Tolimidone is a pyrazolopyrimidine derivative and immunomodulator primarily utilized in oncology research for its potential to treat multiple myeloma by inhibiting the proliferation of malignant plasma… Read more
Tolimidone is a pyrazolopyrimidine derivative and immunomodulator primarily utilized in oncology research for its potential to treat multiple myeloma by inhibiting the proliferation of malignant plasma cells. As this compound functions by interfering with protein synthesis and inducing apoptosis in cancer cells, analytical laboratories require high-quality reference materials to support pharmaceutical development and regulatory compliance. This category contains Tolimidone reference standards and related impurities, such as Tolimidone impurity 1, which are critical for accurate impurity profiling and structural elucidation. These compounds enable researchers and quality control laboratories to perform precise method validation, ensure the accuracy of quantitative analyses, and meet strict standards during the development of therapeutic formulations. By utilizing these characterized reference materials, scientists can effectively monitor product quality and investigate degradation pathways throughout the drug discovery and manufacturing processes.